医学
黄斑变性
眼科
黄斑水肿
荟萃分析
视网膜静脉
糖尿病性黄斑水肿
糖尿病性视网膜病变
视网膜
视网膜分支静脉阻塞
闭塞
视网膜中央静脉阻塞
糖尿病
外科
内科学
内分泌学
作者
Prem Nichani,Marko M. Popovic,Andrew Mihalache,Ananya Pathak,Rajeev H. Muni,David T. Wong,Peter J. Kertes
摘要
Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has become the mainstay of treatment in many retinal diseases. The comparative efficacy and safety of newer bispecific anti-VEGF/angiopoietin 2 (Ang2) agents in the treatment paradigm versus widely used monospecific anti-VEGF agents remains unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI